Articles

Marvell’s stock seesaws as ‘exceptional’ AI demand drives a stronger growth outlook

The custom-chip maker says revenue growth is expected “to continue accelerating each quarter” for the rest of the fiscal year.

The surge in chip stocks this year is putting the dot-com rally to shame

All of the stocks in the PHLX Semiconductor Index are up more than 10% so far this year

Salesforce shares sink on soft revenue outlook as AI disruption concerns linger

While the company’s Agentforce offering is picking up steam, Salesforce didn’t deliver the top-line growth investors wanted to see

More Americans are raiding their emergency savings just to fill up their gas tanks

Most people think of emergencies as job loss or a hospital bill. For many today, it’s soaring energy costs.

Investors are rushing to buy TIPS ETFs to beat inflation. They could end up losing.

Inflation-protected funds don’t always protect against inflation. As consumer-price inflation hits a three-year high due to the Iran war, the premise in their names is being tested.

Zscaler’s stock seeing record drop after investors are blindsided by a disappointing outlook

Shares of Zscaler were headed for a record one-day decline of more than 31% after the cybersecurity company shocked investors with a downbeat revenue outlook.

Investors betting the Iran war is ending are buying up travel stocks

Shares of travel names Delta, United and MGM were among the S&P 500’s biggest gainers on Wednesday. But one strategist called the market’s optimism misplaced.

Here’s how to find out if you’re one of millions of Americans who can claim this IRS refund

Time’s running out to file for a COVID-era refund that could get you thousands of dollars back

The death of Nascar driver Kyle Busch is renewing the debate around indexed universal life insurance

If you’re looking for a “sure thing” in a retirement plan, indexed universal life is probably not the answer.

Momentus’s stock nearly triples in 2 days as the space company raises more cash from investors

Momentus investors continue to cheer as the space firm secures more cash through a private placement of stock.

Cancer treatment already costs hundreds of thousands of dollars — and it’s about to get even worse

Someone who survived brain cancer in the 1990s explains how the Affordable Care Act could have helped.

Micron investors are partying like it’s 1987, and the stock still looks pretty cheap

Shares of Micron were headed for their best monthly performance since 1987, but analysts still see them as a value play.
1 4 5 6 7 8 2,611